These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3631918)

  • 21. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
    Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
    Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of acute tryptophan depletion on cognition, memory and motor performance in Parkinson's disease.
    Scholtissen B; Verhey FR; Adam JJ; Prickaerts J; Leentjens AF
    J Neurol Sci; 2006 Oct; 248(1-2):259-65. PubMed ID: 16756999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R; Scheltens P; Barkhof F; Rombouts SA
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The mental state of parkinsonian patients].
    Dubois B
    Rev Prat; 1989 Mar; 39(8):658-61. PubMed ID: 2727573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
    Leroi I; Brandt J; Reich SG; Lyketsos CG; Grill S; Thompson R; Marsh L
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of neuropsychological performance according to the age of onset in subjects with Parkinson's disease and Parkinsonism].
    Ruiz-Rizzo AL; Tirado V; Moreno-Carrillo C; Aguirre-Acevedo DC; Murillo O; Lopera F
    Rev Neurol; 2009 Aug 1-15; 49(3):123-30. PubMed ID: 19621306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing peripheral and central cholinergic system responses.
    Naranjo CA; Fourie J; Herrmann N; Lanctôt KL; Birt C; Yau KK
    J Psychiatry Neurosci; 2000 Sep; 25(4):325-36. PubMed ID: 11022397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive [correction of cognitve] estimation: comparison of two tests in nondemented parkinsonian patients.
    Appollonio IM; Russo A; Isella V; Forapani E; Villa ML; Piolti R; Frattola L
    Neurol Sci; 2003 Oct; 24(3):153-4. PubMed ID: 14598062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pupillometric findings in patients with Parkinson's disease and cognitive disorder.
    Stergiou V; Fotiou D; Tsiptsios D; Haidich B; Nakou M; Giantselidis C; Karlovasitou A
    Int J Psychophysiol; 2009 May; 72(2):97-101. PubMed ID: 19047001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
    Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
    Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Explicit and procedural memory in Parkinson's disease.
    Allain H; Lieury A; Thomas V; Reymann JM; Gandon JM; Belliard S
    Biomed Pharmacother; 1995; 49(4):179-86. PubMed ID: 7669937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of cognitive impairment in a population of patients with Parkinson's disease by means of the mini mental Parkinson test].
    Parrao-Díaz T; Chaná-Cuevas P; Juri-Claverías C; Kunstmann C; Tapia-Núñez J
    Rev Neurol; 2005 Mar 16-31; 40(6):339-44. PubMed ID: 15795869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive decline in Parkinson's disease: a prospective longitudinal study.
    Muslimović D; Post B; Speelman JD; De Haan RJ; Schmand B
    J Int Neuropsychol Soc; 2009 May; 15(3):426-37. PubMed ID: 19402929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cognitive disorders in Parkinson's disease without dementia].
    Lévy R; Pillon B
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4 Spec No 1():S25-34. PubMed ID: 23631045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cognitive impairment in Parkinson's disease].
    Tamaru F; Yanagisawa N
    No To Shinkei; 1991 Aug; 43(8):731-40. PubMed ID: 1931256
    [No Abstract]   [Full Text] [Related]  

  • 37. [Memory disorders in parkinsonism patients].
    Jacobi P; Schneider E; Fischer PA
    Fortschr Neurol Psychiatr Grenzgeb; 1976 Feb; 44(2):63-72. PubMed ID: 1044595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective deficits in cognition and memory in high-functioning parkinsonian patients.
    Mohr E; Juncos J; Cox C; Litvan I; Fedio P; Chase TN
    J Neurol Neurosurg Psychiatry; 1990 Jul; 53(7):603-6. PubMed ID: 2391526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semantic activation in patients with Parkinson's disease.
    Hines TM; Volpe BT
    Exp Aging Res; 1985; 11(2):105-7. PubMed ID: 4092717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance.
    Calabresi P; Picconi B; Parnetti L; Di Filippo M
    Lancet Neurol; 2006 Nov; 5(11):974-83. PubMed ID: 17052664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.